Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · IEX Real-Time Price · USD

0.720

-0.021 (-2.89%)

At close: Jul 2, 2024, 4:00 PM

0.724

+0.004 (0.56%)

After-hours: Jul 2, 2024, 7:10 PM EDT

Monopar Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Net Income	-8.4	-10.52	-9.1	-6.3	-4.22	Upgrade
Share-Based Compensation	1.9	1.64	1.47	1.32	1.01	Upgrade
Other Operating Activities	-1.35	1.65	0.32	0.32	0.2	Upgrade
Operating Cash Flow	-7.86	-7.23	-7.32	-4.66	-3.02	Upgrade
Change in Investments	4.93	-4.92	0	0	0	Upgrade
Investing Cash Flow	4.93	-4.92	0	0	0	Upgrade
Share Issuance / Repurchase	2.07	0.11	10.94	8.18	9.36	Upgrade
Debt Issued / Paid	0	0	0	0.12	0	Upgrade
Other Financing Activities	-0.05	-0.08	-0.06	-0.12	-0.01	Upgrade
Financing Cash Flow	2.03	0.03	10.88	8.18	9.35	Upgrade
Exchange Rate Effect	-0.02	-0	0	0	-0.01	Upgrade
Net Cash Flow	-0.92	-12.12	3.57	3.52	6.32	Upgrade
Free Cash Flow	-7.86	-7.23	-7.32	-4.66	-3.02	Upgrade
Free Cash Flow Per Share	-0.57	-0.57	-0.59	-0.42	-0.32	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).